Novel Lung Simulator Helps Oncologists Deliver Radiation More Precisely
SegAna Helps Oncologists Deliver Radiation More Precisely
Innovation Dedicated to Saving Lives for Patients with Lung Cancer
4D Lung Phantoms Uploaded with Patient Specific Breathing Parameters
Created for Targeted Therapy and Enhancing Radiation Treatment
SegAna LLC is a medical technology startup company that will manufacture and sell deformable four-dimensional (4-D) lung phantoms, simulators and supporting software for enhancing lung cancer radiation treatment.
Each lung phantom is 3-D printed with the patient’s specific elastic and radiographic properties which, when coupled with SegAna’s simulator, enables the physician to develop precise patient treatment parameters. SegAna’s software facilitates clinical decision-making for adaptive radiotherapy.
The company’s patent pending state-of-the-art technology enhances the treatment of lung cancer by providing radiation oncologists with the tools to accurately treat the tumor during normal breathing of the lung. Radiation damage to the lung tissue or organs surrounding the tumor may be reduced, leading to an improved patient outcome.
Mission and Vision
SegAna’s mission is to develop 4-D phantoms and supporting software to provide cancer treatment centers with technology to enhance patient treatment parameters and improve patient outcomes.
The company’s long-term vision is to be recognized as the leading cancer simulator company focused on providing physicians with the necessary tools to greatly reduce a patient’s adverse events and enhance their quality of life.